WO2019151486A1 - 機能性多糖粒子 - Google Patents
機能性多糖粒子 Download PDFInfo
- Publication number
- WO2019151486A1 WO2019151486A1 PCT/JP2019/003646 JP2019003646W WO2019151486A1 WO 2019151486 A1 WO2019151486 A1 WO 2019151486A1 JP 2019003646 W JP2019003646 W JP 2019003646W WO 2019151486 A1 WO2019151486 A1 WO 2019151486A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cellulose
- acid
- extract
- particles
- oil
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0245—Specific shapes or structures not provided for by any of the groups of A61K8/0241
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B15/00—Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/10—General cosmetic use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/26—Optical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/60—Particulates further characterized by their structure or composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95
Definitions
- the present invention relates to particles having a ridge-like or ridge-like uneven structure on the surface and containing cellulose or a cellulose derivative as a main component, a method for producing the same, and a cosmetic containing the particles.
- Porous fine particles are used in various fields as various additives such as abrasives, matting agents (light diffusing agents), carriers, water-absorbing materials, fillers, anti-blocking agents, etc., depending on the material, shape, physical properties, etc. Has been.
- microbeads generally refer to microparticles made of plastics such as polyethylene and polypropylene (particles of several ⁇ m to several hundred ⁇ m), toiletry products (for example, facial cleansers, body cleaning materials), and oral care products. It is also widely used in cosmetics such as (for example, dentifrice) and cosmetics (for example, foundation). Specifically, microbeads are used as a scrub agent to enhance the massage effect and cleaning effect in toiletry products such as facial cleansers and body cleaning materials, and in cosmetics such as foundations, for example, reflected light is directed in multiple directions. It is used to develop a defocus effect (also referred to as soft focus effect) that corrects skin defects such as scattering, spots, wrinkles, freckles, and color irregularities (see, for example, Patent Documents 1 and 2).
- a defocus effect also referred to as soft focus effect
- microbeads pass through sewage treatment and flow into rivers and oceans and are taken into living organisms and have an adverse effect on the ecosystem. Since microbeads are almost impossible to recover once they flow into the environment, it is required to replace plastic microbeads with environmentally friendly materials such as biodegradable plastics and natural materials.
- environmentally friendly materials such as biodegradable plastics and natural materials.
- porous resin fine particles mainly composed of a polyester-based thermoplastic resin having biodegradability have been reported (for example, see Patent Document 3).
- Cellulose particles are known as microbeads derived from natural materials (see, for example, Patent Document 4).
- an object of the present invention is to provide cellulose particles which are natural materials and are soft and have excellent light scattering properties.
- the present inventors have found that particles obtained by spray-drying a dispersion of cellulose or a cellulose derivative, particularly a plant-derived cellulose nanofiber, have a moderate degree of crystallinity, and have a cocoon shape on the surface.
- the present invention has been completed by finding that it has a bowl-shaped uneven structure and is soft and excellent in light scattering and oil absorption.
- the present invention is as follows.
- It has a step of obtaining a dispersion of cellulose or a cellulose derivative and a step of spray drying the obtained dispersion, and has a bowl-like or bowl-like concavo-convex structure on the surface, and has a crystallinity of 80% or less.
- the step of obtaining a dispersion of cellulose or a cellulose derivative and the step of spray-drying the obtained dispersion have a light scattering rate in the range of 50 to 230%, and is mainly composed of cellulose or a cellulose derivative. Particle production method.
- the particles of the present invention are moderately suppressed in crystallinity and have a wrinkle-like or wrinkle-like uneven structure on the surface, so that they are soft and suitable for addition to cosmetics that directly touch the skin.
- the particles of the present invention are excellent in oil absorbency, and thus are suitable for addition to cosmetics containing oily components and oily bases, and have excellent optical properties (light scattering properties) that incident light is uniformly scattered. Therefore, it can be expected to develop a defocus effect (also referred to as a soft focus effect) by blending into cosmetics such as foundations.
- FIG. 2 is a transmission electron microscope (TEM) photograph of the cross section of the particle obtained in Example 1.
- TEM transmission electron microscope
- (A) is a powder X-ray diffraction diagram of the particles obtained in Example 1
- (b) is a powder X-ray diffraction diagram of the particles obtained in Example 3
- (c) is that of Comparative Example 1. It is a powder X-ray diffraction diagram of commercially available cellulose particles.
- (A) is the volume particle size distribution and passage fraction accumulation of the particles obtained in Example 1
- (b) is the volume particle size distribution and passage accumulation of the particles obtained in Example 2
- (c) is
- D) is the volume particle size distribution and passage integral of the particles obtained in Example 4
- (e) is the embodiment 5. It is the volume particle size distribution of the obtained particles and the integrated amount of passage.
- the present invention relates to particles having a ridge-like or ridge-like uneven structure on the surface and containing cellulose or a cellulose derivative as a main component.
- “having a bowl-like or bowl-shaped uneven structure” means a groove shape having a bowl-like or bowl-like appearance when its surface is not smooth when an enlarged image of the particle is observed. It means having a straight line. This shows an irregular concavo-convex structure found in petal-like particles, unlike a hollow crater-like crater found in other porous spherical cellulose particles.
- grains of this invention contain a cellulose or a cellulose derivative as a main component.
- Cellulose or cellulose derivatives used in the present invention are natural fibers such as wool, cotton, silk, hemp, pulp, etc., such as rayon, polynosic, cupra (Bemberg (registered trademark)), lyocell (Tencel (registered trademark)), etc. Examples include those derived from fibers or cellulose produced by bacteria. Moreover, you may originate from the cellulose composite fiber of a cellulose fiber and synthetic fibers (for example, polyolefin fiber, such as polyethylene and a polypropylene).
- Examples of the cellulose or cellulose derivative used in the present invention include those derived from natural fibers, for example, those derived from plants such as wood, bamboo, hemp, jute, kenaf, cotton, beet, agricultural waste, In particular, those derived from broad-leaved trees, conifers or bamboo are mentioned. Further, ⁇ -cellulose obtained from such a fibrous plant may be partially purified by depolymerization with an acid, for example, crystalline cellulose.
- cellulose fibers particularly cellulose nanofibers, as cellulose or cellulose derivatives.
- Cellulose nanofiber (CNF) is a fiber obtained by defibrating cellulose fiber to a nanosize level, and is generally a fiber having a fiber width of about 4 to 200 nm and a fiber length of about 5 ⁇ m or more.
- Such a cellulose nanofiber can be prepared by a known method or can be obtained as a commercial product. For example, it can be obtained from suppliers such as Daio Paper Co., Ltd. and Chuetsu Pulp Industry Co., Ltd.
- “comprising cellulose or a cellulose derivative as a main component” means that the ratio (by weight) of cellulose or cellulose derivative in the particles is more than 50% by mass.
- the ratio (weight basis) of cellulose or cellulose derivative is preferably 60% by mass or more, more preferably 70% by mass or more, still more preferably 80% by mass or more, and particularly preferably 90% by mass or more.
- the particles of the present invention consist only of cellulose or cellulose derivatives.
- ingredients other than cellulose or cellulose derivatives contained in the particles include inorganic pigments and clay minerals, such as mica, talc, kaolin, sericite, montmorillonite, kaolinite, mica, muscovite, phlogopite, synthetic mica, Phlogopite, biotite, permiculite, magnesium carbonate, calcium carbonate, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, zeolite, barium sulfate, calcined calcium sulfate, Calcium phosphate, fluorapatite, hydroxyapatite, ceramic powder, bentonite, smectite, clay, mud, metal soap (for example, zinc myristate, calcium palmitate, aluminum stearate), calcium carbonate , Bengala, yellow iron oxide, black iron oxide, ultramarine, bitumen, carbon black, titanium oxide, fine and ultrafine titanium oxide, zinc oxide, fine and ultrafine
- the particle size of the particles of the present invention can be appropriately set according to the desired use of the particles.
- the particle size is in the range of 0.5 to 500 ⁇ m, preferably 1 to 200 ⁇ m, more preferably 2 to 100 ⁇ m, and particularly preferably 5.
- the average particle size is, for example, in the range of 5 to 40 ⁇ m, and preferably in the range of 5 to 30 ⁇ m.
- the particle size means a value measured by a scattering type particle size distribution measuring device, and the average particle size means an arithmetic average diameter calculated from the obtained particle size distribution.
- the particles of the present invention have a light scattering rate represented by the following formula (1) in the range of 50 to 200%.
- the reflection intensity at angles of 20 °, 70 °, and 5 ° is a light receiver when light is incident on the particle from an angle of ⁇ 30 ° with the normal direction to the particle being 0 °. Is set to an arbitrary value (referred to as a sensitivity adjustment value), and the intensity of the reflected light when the angle of the light receiver is 20 °, 70 ° and 5 ° when light is incident from a certain angle.
- the light scattering rate is calculated according to the above formula (1) described in International Publication No. 2010/092890.
- the light scattering rate when the incident angle of light is ⁇ 30 °, when the normal direction of the surface against which the sample is pressed is 0 °, the light is incident on the sample from an angle of ⁇ 30 °.
- the sensitivity of the light receiver is set to an arbitrary value (referred to as sensitivity adjustment value)
- the intensity of the reflected light is measured when the angles of the light receiver are 20 °, 70 °, and 5 °.
- the intensity of the reflected light is measured when the angle of the light receiver is 20 °, 70 ° and 5 ° when light is incident on the same sample from an angle of ⁇ 45 °.
- the relative intensity is measured in the same manner, and the light scattering rate is finally calculated.
- the graph showing the reflection intensity shown in FIG. 2 becomes circular, which means that the incident light is uniformly diffused.
- the graph showing the reflection intensity shown in FIG. 2 means a horizontally long ellipse.
- the light scattering rate is less than 100, it means a vertically long ellipse. To do.
- the particles of the present invention have a more uniform reflected light intensity despite having a bowl-like or bowl-like uneven structure on the surface.
- the particles of the present invention are characterized by having a light scattering rate in the range of 50 to 230%.
- the light scattering rate is preferably in the range of 50 to 230% at any one incident angle, more preferably arbitrary
- the light scattering rate is in the range of 50 to 230% at these two incident angles, and more preferably, the light scattering rate is in the range of 50 to 230% at any incident angle.
- the light scattering rate of the particles of the present invention is preferably in the range of 50 to 200%, more preferably in the range of 70 to 190%, and still more preferably in the range of 75 to 190%. This means that the particles of the present invention can enable more uniform omnidirectional reflection. For example, when the particles of the present invention are used as cosmetic additives, a defocus effect can be expected.
- the vicinity of the incident light having the maximum intensity of the reflected light in the vicinity of the regular reflection with respect to the incident light for example, the regular reflection angle is within ⁇ 10 °, preferably the regular reflection angle is within ⁇ 5 °
- the ratio of the incident light angle within ⁇ 10 °, preferably within the incident light angle ⁇ 5 °, to the maximum intensity of the reflected light is preferably in the range of 0.5: 1 to 2: 1. It is preferably in the range of 5: 1 to 1.8: 1.
- the particles of the present invention are characterized by a crystallinity of 80% or less.
- the crystallinity of the present invention means the ratio of crystal regions in cellulose in the particles.
- I 22.6 and I 18.5 represents the diffraction intensity diffraction angle 2 ⁇ is in the 22.6 ° and 18.5 °
- I 22.6, blank and I 18.5, blank the diffraction angle 2 ⁇ Shows the diffraction intensity of the glass capillary only at 22.6 ° and 18.5 °.
- I 20.0 and I 15.0 represents the diffraction intensity diffraction angle 2 ⁇ is in the 20.0 ° and 15.0 °
- I 20.0, blank and I 15.0, blank each diffraction angle The diffraction intensity of the glass capillary only when 2 ⁇ is 20.0 ° and 15.0 ° is shown.
- the crystallinity of the cellulose particles increases, the strength generally improves, but the flexibility decreases, so it is desirable that the crystallinity is moderately suppressed. Accordingly, the crystallinity of the particles of the present invention is 80% or less, preferably 75% or less, and more preferably 70% or less. On the other hand, the degree of crystallinity of the particles of the present invention is 20% or more, preferably 25% or more, more preferably 30% or more.
- the particles of the present invention are moderately suppressed in crystallinity and have a wrinkle-like or wrinkle-like uneven structure on the surface thereof, so that they are soft and suitable for addition to cosmetics that directly touch the skin.
- the particles of the present invention are characterized in that the oil absorption measured according to JIS K 5101-13-1 is in the range of 60 to 150 g / 100 g.
- the oil absorption of the particles of the present invention is in the range of 60 to 150 g / 100 g, preferably in the range of 60 to 100 g / 100 g, and is suitable for addition to cosmetics containing an oily component or an oily base.
- the particles of the present invention can be produced by a method comprising a step of obtaining a dispersion of cellulose or a cellulose derivative and a step of spray drying the obtained dispersion.
- the dispersion is obtained by mixing cellulose or a cellulose derivative and a dispersion medium and pulverizing the mixture.
- the dispersion medium is preferably an aqueous medium, more preferably water, a water-miscible organic solvent, or a mixture thereof.
- water miscible organic solvents include alcohols having 1 to 4 carbon atoms such as methanol, ethanol, isopropyl alcohol and butanol, ketones such as acetone, nitriles such as acetonitrile, N-methylpyrrolidone, N-cyclohexylpyrrolidone Amides such as N, N-dimethylacetamide and N, N-dimethylformamide, lactones such as ⁇ -butyrolactone, and ethers such as tetrahydrofuran.
- the dispersion medium is water or a mixture of water and an alcohol having 1 to 4 carbon atoms.
- the concentration of cellulose or cellulose derivative in the dispersion is not particularly limited as long as it can be used in the subsequent spray-drying step, but is, for example, 0.01 to 10% by mass, preferably 0.3 to 7% by mass, More preferably, it is 0.5 to 5% by mass.
- the operation for obtaining the dispersion is not particularly limited, and can be carried out using an operation for obtaining a dispersion known to those skilled in the art.
- the dispersion is obtained by pulverizing cellulose or a cellulose derivative, and preferably by physical pulverization.
- Physical pulverization refers to a mixture of cellulose or a cellulose derivative and a dispersion medium, a magnetic stirrer, a stirring device such as a stirring blade, a homogenizer such as polytron, an ultrasonic generator such as an ultrasonic crusher, a wet atomizer ( For example, it is carried out by applying a physical external force using a pulverizer such as Starburst (Sugino Machine Co., Ltd.).
- a dispersion may be obtained without performing the grinding treatment.
- it may replace with the process of obtaining a dispersion liquid, and may use a commercially available cellulose dispersion liquid, for example, the dispersion liquid of a commercially available cellulose nanofiber.
- the particles of the present invention can be obtained by spray-drying the obtained dispersion.
- the spray drying is performed using a known spray drying apparatus such as a spray dryer.
- the spray drying conditions are appropriately set according to the type of dispersion medium in the dispersion, the type or concentration of cellulose or cellulose derivative, and the like, for example, at an inlet temperature of 150 to 300 ° C. and an outlet temperature of 0 to 150 ° C. .
- the particles of the present invention have an excellent optical characteristic (light scattering property) that the degree of crystallinity is moderately suppressed, the surface thereof has a bowl-like or bowl-like uneven structure, is soft, and incident light is uniformly scattered. ), It is suitable for addition to cosmetics that directly touch the skin and require optical properties such as a defocus effect.
- the particles of the present invention may be used as a cosmetic additive or a cosmetic composition by itself or in a form dispersed with an optional additive in an appropriate medium according to the application.
- Such cosmetics include facial cleansing foams, facial cleansing powders, toiletry products such as body cleansers, hair care products such as shampoos and conditioners, oral care products such as dentifrices, makeup bases, powder foundations, liquid foundations, and BB creams.
- Makeup cosmetics such as concealer and sunscreen, and the like. In these, it can be used as a scrub agent for enhancing the massage effect and the cleaning effect, or as a light scattering agent for developing a defocus effect.
- the particles of the present invention are excellent in oil absorption, they are suitable for addition to cosmetics containing an oil component and an oil base.
- the cosmetics of the present invention can be blended with additives that can generally be used as cosmetic additives and quasi-drug additives as required.
- an additive component such as a physiologically active substance and a functional substance to be blended in an external preparation for skin such as cosmetics or quasi-drugs, for example, an oily base, a moisturizing agent, a feeling improver, a surfactant, a polymer, a thickening agent Gelling agent, solvent, propellant, antioxidant, reducing agent, oxidizing agent, antiseptic, antibacterial agent, bactericidal agent, chelating agent, pH adjuster, acid, alkali, powder, inorganic salts, UV absorber, Whitening agents, vitamins and derivatives thereof, hair growth agents, blood circulation promoters, stimulants, hormones, anti-wrinkle agents, anti-aging agents, squeeze agents, cooling sensation agents, warming sensation agents, wound healing promoters, stimulation relief Agent, analgesic agent, cell activator, plant / animal / microbe extract
- additive components include cetanol, myristyl alcohol, oleyl alcohol, lauryl alcohol, cetostearyl alcohol, stearyl alcohol, aralkyl alcohol, behenyl alcohol, jojoba alcohol, chimyl alcohol, seraalkyl alcohol, batyl.
- Higher (polyhydric) alcohols such as alcohol, hexyldecanol, isostearyl alcohol, 2-octyldodecanol, dimer diol; aralkyl alcohols such as benzyl alcohol and their derivatives; lauric acid, myristic acid, palmitic acid, stearic acid, isostearic acid , Behenic acid, undecylenic acid, 12-hydroxystearic acid, palmitoleic acid, oleic acid, linoleic acid, linolenic acid, erucic acid, docosahexa Higher fatty acids such as enoic acid, eicosapentaenoic acid, isohexadecanoic acid, anteisohenicosanoic acid, long chain branched fatty acid, dimer acid, hydrogenated dimer acid, and aluminum salts, calcium salts, magnesium salts, zinc salts thereof, Metal soaps such as potassium salts and sodium salt
- humectants and feel improvers examples include glycerin, 1,3-butylene glycol, propylene glycol, 3-methyl-1,3-butanediol, 1,3-propanediol, 2-methyl-1,3-propanediol, Polyols such as trimethylolpropane, pentaerythritol, hexylene glycol, diglycerin, polyglycerin, diethylene glycol, polyethylene glycol, dipropylene glycol, polypropylene glycol, ethylene glycol / propylene glycol copolymer and polymers thereof; diethylene glycol monoethyl ether (Ethoxydiglycol), ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, diethylene glycol dibutyl ether, etc.
- Ethoxydiglycol ethylene glycol monoethyl ether
- ethylene glycol monobutyl ether diethylene glycol dibutyl
- Water-soluble esters such as polyglyceryl-10 and tetradecandioic acid polyglyceryl-10; sugar alcohols such as sorbitol, xylitol, erythritol, mannitol, maltitol; glucose, fructose, galactose Mannose, threose, xylose, arabinose, fucose, ribose, deoxyribose, maltose, trehalose, lactose, raffinose, gluconic acid, glucuronic acid, cyclodextrins ( ⁇ -, ⁇ -, ⁇ -cyclodextrin, and maltosylation, Modified cyclodextrins such as hydroxyalkylation), ⁇ -glucan, chitin, chitosan, heparin and derivatives, pectin, arabinogalactan, dextrin, dextran, glycoge Sugars and
- the surfactant include an anionic surfactant, a nonionic surfactant, a cationic surfactant, an amphoteric surfactant, and a polymer surfactant.
- preferable surfactants include anionic surfactants such as sodium laurate, sodium myristate, sodium palmitate, sodium stearate, potassium laurate, potassium myristate, and the like; sodium lauryl sulfate Alkyl sulfates such as lauryl sulfate, triethanolamine and ammonium lauryl sulfate; polyoxyethylene alkyl sulfates such as sodium laureth sulfate and triethanolamine laureth sulfate; sodium cocoyl methyl taurate, potassium cocoyl methyl taurine, sodium lauroyl methyl taurine, myristoyl Sodium methyl taurine, sodium lauroylmethylalanine, sodium lauroyl sarcosine, lauroyl sarcosine triethanol
- Nonionic surfactants include laureth (polyoxyethylene lauryl ether), ceteth (polyoxyethylene) Cetyl ether), steareth (polyoxyethylene stearyl ether), behenes (polyoxyethylene behenyl ether), isosteares (polyoxyethylene isostearyl ether), octyldecesses (polyoxyethylene octyldodecyl ether) Polyoxyethylene alkyl ethers with polyoxyethylene addition number; polyoxyethylene alkylphenyl ether; polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil monoisostearate, polyoxyethylene hydrogenated castor oil Castor oil such as triisostearate, polyoxyethylene hydrogenated castor oil monopyroglutamic acid monoisostearic acid diester, polyoxyethylene hydrogenated castor oil maleic acid, etc.
- nonionic surfactants include laureth (polyoxyethylene lauryl ether), cet
- Hardened castor oil derivative polyoxyethylene phytosterol; polyoxyethylene cholesterol; polyoxyethylene cholestanol; polyoxyethylene lanolin; polyoxyethylene reduced lanolin; polyoxyethylene / polyoxypropylene cetyl ether, polyoxyethylene / polyoxypropylene Polyoxyethylene / polyoxypropylene alkyl ethers such as 2-decyltetradecyl ether, polyoxyethylene / polyoxypropylene monobutyl ether, polyoxyethylene / polyoxypropylene hydrogenated lanolin, polyoxyethylene / polyoxypropylene glycerin ether; Oxyethylene / polyoxypropylene glycol; (poly) glycerin polyoxypropylene such as PPG-9 diglyceryl Recall: glyceryl stearate, glyceryl isostearate, glyceryl palmitate, glyceryl myristate, glyceryl oleate, glyceryl coconut oil fatty acid, mono-cotton
- Polyoxyethylene / propylene glycol fatty acid esters polyoxyethylene glycerol monostearate, polyoxyethylene glycerol monoisostearate, polyoxyethylene glycerol triisostearate, and other polyoxyethylene monooleates Polyoxyethylene glycerin fatty acid ester; polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene sorbitan fatty acid ester such as polyoxyethylene sorbitan tetraoleate; polyoxyethylene sorbitol Monolaurate, polyoxyethylene sorbitol monooleate, polyoxyethylene sorbitol penta Polyoxyethylene sorbitol fatty acid esters such as leates and polyoxyethylene sorbitol monostearate; polyoxyethylene methyl glucoside fatty acid esters; polyoxyethylene alkyl ether fatty acid esters; polyoxyethylene animal and vegetable oils such as polyoxyethylene
- Polymers, thickeners and gelling agents include guar gum, locust bean gum, queens seed, carrageenan, galactan, arabic gum, tara gum, tamarind, far selelain, karaya gum, troarooi, cara gum, tragacanth gum, pectin, pectic acid and sodium Salt such as salt, salt such as alginic acid and sodium salt, mannan; starch such as rice, corn, potato, wheat; xanthan gum, dextran, succinoglucan, curdlan, hyaluronic acid and its salt, xanthan gum, pullulan, gellan gum, chitin , Chitosan, agar, gypsophila extract, chondroitin sulfate, casein, collagen, gelatin, albumin; methylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypro Cellulose, hydroxypropylmethylcellulose, carboxymethylcellulose and salts thereof such as
- Acrylic acid / methyl acrylate / methacrylamidopropyltrimethylammonium chloride copolymer such as polyquaternium-47, methacrylic acid choline ester polymer; cationized oligosaccharide, cationized dextran, guar hydroxypropyltri Cationic polysaccharides such as monium chloride; polyethyleneimine; cationic polymers; copolymers of 2-methacryloyloxyethyl phosphorylcholine such as polyquaternium-51 and copolymers of butyl methacrylate; acrylic resin emulsion, polyacrylic acid Polymer emulsions such as ethyl emulsion, polyacrylic alkyl ester emulsion, polyvinyl acetate resin emulsion, natural rubber latex, synthetic latex; nitrocellulose; Tans and various copolymers; Various silicones; Various silicone-based copolymers such as acrylic-silicone graft
- Solvents include lower alcohols such as ethanol, 2-propanol (isopropyl alcohol), butanol and isobutyl alcohol; glycols such as propylene glycol, 1,3-butylene glycol, diethylene glycol, dipropylene glycol and isopentyl diol; diethylene glycol mono Glycol ethers such as ethyl ether (ethoxydiglycol), ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, triethylene glycol monoethyl ether, diethylene glycol diethyl ether, diethylene glycol dibutyl ether, propylene glycol monoethyl ether, dipropylene glycol monoethyl ether Class: Ethylene glycol monoethyl ether acetate Glycol ether esters such as diethylene glycol monoethyl ether acetate and propylene glycol monoethyl ether acetate; glycol esters such as die
- Antioxidants include tocopherol derivatives such as tocopherol (vitamin E) and tocopherol acetate; BHT, BHA; gallic acid derivatives such as propyl gallate; vitamin C (ascorbic acid) and / or derivatives thereof; erythorbic acid and derivatives thereof; Preferred are sulfites such as sodium sulfite; bisulfites such as sodium bisulfite; thiosulfates such as sodium thiosulfate; metabisulfites; thiotaurine, hypotaurine; thioglycerol, thiourea, thioglycolic acid, cysteine hydrochloride As mentioned.
- Preferred examples of the reducing agent include thioglycolic acid, cysteine, cysteamine and the like.
- Preferred examples of the oxidizing agent include aqueous hydrogen peroxide, ammonium persulfate, sodium bromate, and percarbonate.
- preservatives, antibacterial agents, and bactericides include hydroxybenzoic acid such as methylparaben, ethylparaben, propylparaben, and butylparaben, and salts or esters thereof; salicylic acid; sodium benzoate; phenoxyethanol; methylchloroisothiazolinone, methylisothiazo Isothiazolinone derivatives such as linone; imidazolinium urea; dehydroacetic acid and its salts; phenols; halogenated bisphenols such as triclosan, acid amides, quaternary ammonium salts; trichlorocarbanide, zinc pyrithione, benzalkonium chloride, chloride Benzethonium, sorbic acid, chlorhexidine, chlorhexidine gluconate, halocarban, hexachlorophene, hinokitiol; phenol, isopropylphenol, cresol, Mall
- chelating agents include edetate (ethylenediaminetetraacetate) such as EDTA, EDTA2Na, EDTA3Na, and EDTA4Na; hydroxyethylethylenediaminetriacetate such as HEDTA3Na; pentetate (diethylenetriaminepentaacetate); phytic acid; Phosphonic acid and its sodium salt; sodium oxalate; polyamino acids such as polyaspartic acid and polyglutamic acid; sodium polyphosphate, sodium metaphosphate, phosphoric acid; sodium citrate, citric acid, alanine, dihydroxyethylglycine Gluconic acid, ascorbic acid, succinic acid, and tartaric acid are preferable.
- edetate ethylenediaminetetraacetate
- HEDTA3Na EDTA3Na
- EDTA4Na hydroxyethylethylenediaminetriacetate
- pentetate diethylenetriaminepentaa
- pH adjusters / acids / alkalis include citric acid, sodium citrate, lactic acid, sodium lactate, potassium lactate, glycolic acid, succinic acid, acetic acid, sodium acetate, malic acid, tartaric acid, fumaric acid, phosphoric acid, hydrochloric acid, sulfuric acid , Monoethanolamine, diethanolamine, triethanolamine, isopropanolamine, triisopropanolamine, 2-amino-2-methyl-1,3-propanediol, 2-amino-2-hydroxymethyl-1,3-propanediol, arginine Sodium hydroxide, potassium hydroxide, aqueous ammonia, guanidine carbonate, and ammonium carbonate are preferable.
- powders include mica, talc, kaolin, sericite, montmorillonite, kaolinite, mica, muscovite, phlogopite, synthetic mica, saucite, biotite, permiculite, magnesium carbonate, calcium carbonate, aluminum silicate, and silicic acid.
- Inorganic salts include sodium chloride-containing salts such as salt, common salt, rock salt, sea salt, natural salt; potassium chloride, aluminum chloride, calcium chloride, magnesium chloride, bittern, zinc chloride, ammonium chloride; sodium sulfate, aluminum sulfate, Aluminum sulfate / potassium sulfate (alum), aluminum sulfate / ammonium sulfate, barium sulfate, calcium sulfate, potassium sulfate, magnesium sulfate, zinc sulfate, iron sulfate, copper sulfate; sodium phosphates such as 1Na, 2Na and 3Na phosphates, phosphoric acid Potassium, calcium phosphates and magnesium phosphates are preferred.
- sodium chloride-containing salts such as salt, common salt, rock salt, sea salt, natural salt
- potassium chloride aluminum chloride, calcium chloride, magnesium chloride, bittern, zinc chloride, ammonium chlor
- ultraviolet absorbers examples include paraaminobenzoic acid, paraaminobenzoic acid monoglycerin ester, N, N-dipropoxyparaaminobenzoic acid ethyl ester, N, N-diethoxyparaaminobenzoic acid ethyl ester, and N, N-dimethylparaaminobenzoic acid ethyl ester.
- Benzoic acid ultraviolet absorbers such as esters, N, N-dimethylparaaminobenzoic acid butyl ester, N, N-dimethylparaaminobenzoic acid ethyl ester; Anthranilic acid ultraviolet absorbers such as homomenthyl-N-acetylanthranilate; Salicylic acid And its sodium salt amyl salicylate, menthyl salicylate, homomenthyl salicylate, octyl salicylate, phenyl salicylate, benzyl salicylate, p-isopropanol phenyl salicylate, etc.
- Line absorber Octyl cinnamate, ethyl-4-isopropyl cinnamate, methyl-2,5-diisopropyl cinnamate, ethyl-2,4-diisopropyl cinnamate, methyl-2,4-diisopropyl cinnamate, propyl-p- Methoxycinnamate, isopropyl-p-methoxycinnamate, isoamyl-p-methoxycinnamate, 2-ethylhexyl p-methoxycinnamate (octyl paramethoxycinnamate), 2-ethoxyethyl-p-methoxycinnamate (sinoxate) Cyclohexyl-p-methoxycinnamate, ethyl- ⁇ -cyano- ⁇ -phenylcinnamate, 2-ethylhexyl ⁇ -cyano- ⁇ -phenylcin
- Benzophenone UV absorber 3- (4′-methylbenzylidene) -d, l-camphor, 3-benzylidene-d, l-camphor; 2-phenyl-5-methylbenzoxazole; 2,2′-hydroxy-5- 2- (2′-hydroxy-5′-t-octylphenyl) benzotriazole; 2- (2′-hydroxy-5′-methylphenylbenzotriazole; dibenzalazine; dianisoylmethane; 5- (3 , 3-dimethyl-2-norbornylidene) -3-pentan-2-one; dibenzoylmethane derivatives such as 4-t-butylmethoxydibenzoylmethane; octyl triazone; urocanic acid derivatives such as urocanic acid and ethyl urocanate; 2- (2′-hydroxy-5′-methylphenyl) benzotriazole, 1 Hydantoin derivatives such as (3,4-d
- whitening agents include hydroquinone glycosides such as arbutin and ⁇ -arbutin and their esters; ascorbic acid phosphates such as ascorbic acid, sodium ascorbic acid phosphate and magnesium ascorbic acid phosphate, ascorbic acid Ascorbic acid fatty acid esters such as tetraisopalmitic acid ester, ascorbic acid alkyl ethers such as ascorbic acid ethyl ether, ascorbic acid glucosides such as ascorbic acid-2-glucoside and fatty acid esters thereof, ascorbic acid sulfate ester, tocopheryl ascorbyl phosphate Ascorbic acid derivatives such as kojic acid, ellagic acid, tranexamic acid and its derivatives, ferulic acid and its derivatives, placenta extract, glutathione, oryzanol, butylreso Shinoru, oil-soluble Kamomiraekisu, oil-soluble licorice extract,
- Vitamins and their derivatives include vitamin A such as retinol, retinol acetate, retinol palmitate; thiamine hydrochloride, thiamine sulfate, riboflavin, riboflavin acetate, pyridoxine hydrochloride, pyridoxine dioctanoate, pyridoxine dipalmitate, Flavin adenine dinucleotide, cyanocobalamin, folic acid, nicotinic acid such as nicotinic acid amide / benzyl nicotinate, vitamin B group such as choline; vitamin C such as ascorbic acid and its sodium salt; vitamin D; ⁇ , Vitamin E such as ⁇ , ⁇ , and ⁇ -tocopherol; other vitamins such as pantothenic acid and biotin; ascorbic acid phosphates such as ascorbic acid phosphate sodium salt and ascorbic acid phosphate magnesium salt, Ascorbic acid fatty acid esters
- Plant growth and tinctures such as assembly extract, red pepper tincture, ginger tincture, ginger extract, cantalis tincture; capsaicin, nonyl acid valenylamide, gingeron, ictamol, tannic acid Borneol, cyclandrate, cinnarizine, trazoline, acetylcholine, verapamil, cephalanthin, ⁇ -oryzanol, vitamin E and derivatives such as tocopherol / nicotinic acid tocopherol, ⁇ -oryzanol, nicotinic acid, nicotinic acid amide, nicotinic acid benzyl ester, Inositol hexanicotinate, derivatives such as nicotine alcohol, allantoin, photosensitive element 301, photosensitive element 401, capronium chloride, pentadecanoic acid monoglyceride, flavonol Derivatives, stigmasterol or stigmasterol and its glycoside
- hormones include estradiol, estrone, ethinyl estradiol, cortisone, hydrocortisone, prednisone and the like.
- Other remedies such as anti-wrinkle agents, anti-aging agents, squeeze agents, cooling sensations, warming sensation agents, wound healing promoters, irritation relievers, analgesics, cell activators include retinols, retinoic acids, retinoin Acid tocopheryl; derivatives such as lactic acid, glycolic acid, gluconic acid, fruit acid, salicylic acid and glycosides / esterified products thereof, ⁇ - or such as hydroxycapric acid, long chain ⁇ -hydroxy fatty acid, long chain ⁇ -hydroxy fatty acid cholesteryl ⁇ -hydroxy acids and derivatives thereof; ⁇ -aminobutyric acid, ⁇ -amino- ⁇ -hydroxybutyric acid; carnitine; carnosine; creatine; ceramides, sphingosines; caffeine, xant
- Antioxidant / active oxygen scavengers include catechins; flavones such as quercetin; isoflavones; gallic acid and ester sugar derivatives; polyphenols such as tannin, sesamin, protoanthocyanidin, chlorogenic acid, apple polyphenol; rutin and glycosides, etc.
- antipruritic agents examples include diphenhydramine hydrochloride, chlorpheniramine maleate, camphor, substance-P inhibitor, and the like.
- exfoliating / dissolving agent examples include salicylic acid, sulfur, resorcin, selenium sulfide, pyridoxine and the like.
- antiperspirants examples include chlorohydroxyaluminum, aluminum chloride, zinc oxide, zinc paraphenol sulfonate, and the like.
- Examples of the refreshing agent include menthol and methyl salicylate.
- astringents include citric acid, tartaric acid, lactic acid, aluminum sulfate / potassium, and tannic acid.
- Enzymes include superoxide dismutase, catalase, lysozyme chloride, lipase, papain, pancreatin, protease, and the like.
- Preferred nucleic acids include ribonucleic acid and its salts, deoxyribonucleic acid and its salts, and adenosine triphosphate disodium.
- Anti-inflammatory and anti-inflammatory agents include glycyrrhizic acid and its derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, guaiazulene, allantoin, indomethacin, ketoprofen, ibuprofen, diclofenac, loxoprofen, celecoxib, infliximab, etanercept, zinc oxide, hydroxanthone acetate Prednisone, difedramine hydrochloride, chlorpheniramine maleate; plant extracts such as peach leaf extract and persimmon leaf extract are preferable.
- Anti-asthma drugs, anti-chronic obstructive pulmonary disease drugs, anti-allergic agents, immunomodulators include aminophylline, theophylline, steroids (fluticasone, beclomethasone, etc.), leukotriene antagonists, thromboxane inhibitors, intal, ⁇ 2-stimulants (formoterol, salmeterol, albuterol, tulobuterol, clenbuterol, epinephrine, etc.), tiotropium, ipratropium, dextromethorphan, dimemorphan, bromhexine, tranilast, ketotifen, azelastine, cetirizine, chlorpheniramine, crolimidine, mequitine Sirolimus, methotrexate, cytokine regulators, interferons, omalizumab, protein / antibody formulations are preferred. .
- Preferred examples of the anti-infective and antifungal agents include oseltamivir, zanamivir, and itraconazole.
- cosmetic raw material standards cosmetic ingredient-specific combination ingredient standards, Japan Cosmetic Industry Association ingredient display name list, INCI dictionary (The International Cosmetic Ingredients and Handbooks), quasi-drug ingredients standards, Japanese pharmacopoeia, pharmaceutical additive standards Ingredients listed in the Food Addendum, etc., and the international patent classification IPC described in Japan and other foreign patent gazettes and patent publications (including publications and republications) belonging to the A61K7 and A61K8 classifications It is possible to contain known cosmetic ingredients, pharmaceutical ingredients, food ingredients, etc., in known combinations, blending ratios and blending amounts.
- the particles of the present invention or the light scattering property are excellent, it can be applied to the industrial field as a light diffusing agent or the like.
- the particles of the present invention may be used as a light diffusing agent or a light diffusing composition by itself or in a form dispersed with an optional additive in an appropriate medium according to the application.
- it can be expected to be used as a light diffusing agent or a light diffusing composition for lighting, a diffusion sheet for backlight, or a window film or decorative sheet for building materials.
- Example 1 bamboo-derived cellulose particles
- This dispersion was pulverized 50 times with a wet atomizer Starburst (manufactured by Sugino Machine Co., Ltd.) at a pressure of 220 MPa to obtain a bamboo-derived cellulose nanofiber dispersion.
- 10 g of the obtained dispersion was weighed into a petri dish and dried at 105 ° C. for 1 hour to remove moisture.
- the amount of the obtained residue was measured, and the cellulose concentration (solid content concentration) in water was calculated from the weight difference before and after drying. As a result, the concentration was 2.0% by mass.
- the above-mentioned bamboo-derived cellulose nanofiber dispersion 1575 g was spray-dried at an atomizer rotational speed of 30000 rpm, an inlet temperature of 180 ° C. and a cyclone differential pressure of 0.5 kPa for 75 minutes to obtain 22.6 g of powder as the title particles. During this time, the outlet temperature changed between 130 ° C and 117 ° C.
- Example 2 Hardwood derived cellulose particles
- 400 g of pure water was added to 400 g of hardwood derived cellulose nanofibers (made by Daio Paper Co., Ltd.) having a solid content of 2 mass%, and then stirred for 1 hour with a mechanical stirrer to disperse the hardwood derived cellulose nanofibers.
- 800 g of this dispersion was spray-dried for 26 minutes at an atomizer rotational speed of 30000 rpm, an inlet temperature of 182 ° C. and a cyclone differential pressure of 0.5 kPa to obtain 1.01 g of powder as the title particles.
- the outlet temperature changed between 102 ° C and 77 ° C.
- Example 3 Coniferous-derived cellulose particles
- 400 g of pure water was added to 400 g of softwood derived cellulose nanofibers (made by Daio Paper Co., Ltd.) having a solid content of 2% by mass, and then stirred for 1 hour with a mechanical stirrer to disperse the softwood derived cellulose nanofibers.
- 800 g of this dispersion was spray-dried at an atomizer rotational speed of 30000 rpm, an inlet temperature of 178 ° C., and a cyclone differential pressure of 0.5 kPa for 26 minutes to obtain 2.70 g of powder as the title particles.
- the outlet temperature was constant at 17 ° C.
- Example 4 Crystalline cellulose particles
- 75 g of crystalline cellulose (Fushimi Pharmaceutical Co., Ltd., Compression M101) was dispersed in 750 g of pure water. This dispersion was pulverized 30 times at a pressure of 220 MPa using a wet atomizer Starburst (manufactured by Sugino Machine Co., Ltd.) to obtain a crystalline cellulose dispersion. 10 g of the obtained dispersion was weighed into a petri dish and dried at 105 ° C. for 1 hour to remove moisture. The amount of the obtained residue was measured, and the cellulose concentration (solid content concentration) in water was calculated from the weight difference before and after drying. As a result, the concentration was 4.0% by mass.
- 250 g of pure water is added to 250 g of the above-mentioned crystalline cellulose dispersion to prepare 2.0% by mass of the crystalline cellulose dispersion, spray-dried for 23 minutes at an atomizer rotational speed of 20000 rpm, an inlet temperature of 160 ° C., and a cyclone differential pressure of 0.5 kPa.
- 4.6 g of powder was obtained as the title particles.
- the outlet temperature changed between 109 ° C and 95 ° C.
- Example 5 Crystalline cellulose particles
- the 4.0 mass% crystalline cellulose dispersion obtained in Example 4 was spray-dried at an atomizer rotational speed of 20000 rpm, an inlet temperature of 160 ° C. and a cyclone differential pressure of 0.5 kPa for 25 minutes to give 12.1 g of the title particles.
- a powder was obtained. During this time, the outlet temperature changed between 109 ° C and 93 ° C.
- the reflected light distribution was measured with a goniophotometer GP-5 (Murakami Color Research Laboratory Co., Ltd.). Measurement incident light was performed at three points of ⁇ 30, ⁇ 45, and ⁇ 60 °. The light scattering rate at each incident light angle was calculated according to the following formula (1) (see International Publication No. 2010/092890).
- the samples used were cellulose particles derived from bamboo, hardwood and conifer obtained in Examples 1 to 3.
- Commercially available cellulose particles CELLULOBEADS® D-10 (manufactured by Daito Kasei Kogyo Co., Ltd.) and porous nylon 6 (polyamide 6) powder POMP610 (registered trademark) (manufactured by Toabo Corporation) was used.
- Tables 1 to 3 show the reflection intensity and light scattering rate of the sample in each incident light. The correlation between the incident light angle and the light scattering rate of each sample is shown in Table 4 and FIG. Further, FIGS. 2A and 2B are graphs showing the reflection intensity of the sample of Example 1 and Comparative Example 1 at an incident light of ⁇ 45 °.
- MMD indicates a change in the average friction coefficient, and is an index that represents the smoothness or roughness that is felt when the surface of an object is touched with a human finger.
- MIU indicates an average friction coefficient, and is an index representing the ease of slipping and the difficulty of slipping when touching the surface of an object with a human finger. The smaller the MIU value, the easier it is to slip.
- I 22.6 and I 18.5 represents the diffraction intensity diffraction angle 2 ⁇ is in the 22.6 ° and 18.5 °
- I 22.6, blank and I 18.5, blank the diffraction angle 2 ⁇ Shows the diffraction intensity of the glass capillary only at 22.6 ° and 18.5 °.
- I 20.0 and I 15.0 represents the diffraction intensity diffraction angle 2 ⁇ is in the 20.0 ° and 15.0 °
- I 20.0, blank and I 15.0, blank each diffraction angle The diffraction intensity of the glass capillary only when 2 ⁇ is 20.0 ° and 15.0 ° is shown.
- the crystallinity of the cellulose particles obtained in Examples 1 and 3 was both 70%.
- the crystallinity of the commercially available cellulose particles CELLULOBEADS® D-10 of Comparative Example 1 was 90%.
- phase A and phase B were weighed out in two 300 mL tall beakers, and each was heated and dissolved at about 75 ° C.
- a phase was added to the above-mentioned heated B phase, and a QUICK HOMO MIXER (manufactured by Mizuho Industry Co., Ltd., 5000 rpm, 3 minutes) treatment was performed. Thereafter, the solution was stirred and cooled with a LABORATORY HIGH POWER MIXER (manufactured by ASONE Co., Ltd.) until the liquid temperature reached about 35 ° C.
- w / o the prepared water in oil
- 50 mg of the evaluation particle powder were weighed and used in a medicine spoon.
- a w / o foundation sample containing 5% of each evaluation particle was prepared by kneading uniformly.
- the evaluation particles the cellulose particles obtained in Examples 1 to 3 were used.
- commercially available cellulose particles CELLULOBEADS D-10 (manufactured by Daito Kasei Kogyo Co., Ltd.) were used.
- Nikomulus WO-CF PLUS PEG-10 dimethicone, dimethicone, disteardimonium hectorite, lauryl PEG-9 polydimethylsiloxyethyl dimethicone, tocopherol SILBLEND-91: cyclopentasiloxane, dimethicone, (dimethicone / vinyl dimethicone) cross polymer KF-96L-2CS: Dimethicone KF6028: PEG-9 polydimethylsiloxyethyl dimethicone DISM: Diisostearyl malate
- FAS70CSI-E Titanium oxide dispersion (titanium oxide, cyclopentasiloxane, PEG / PPG-18 / 18 dimethicone, triethoxycaprylylsilane, alumina, tocopherol acetate, silica) Fresh color base: Titanium oxide, cyclopentasiloxane, PEG / P
- Paste black drawing paper PI-N86D manufactured by Maruai Co., Ltd.
- the micro slide glass S1111 manufactured by Matsunami Glass Industry Co., Ltd.
- Nystack registered trademark
- NW-10S manufactured by Nichiban Co., Ltd.
- a w / o foundation containing 5% of each evaluation particle prepared above was spread evenly on the above black drawing paper and air-dried for 20 minutes.
- the reflected light distribution was measured with a goniophotometer GP-5 (Murakami Color Research Laboratory Co., Ltd.).
- the measurement incident light was ⁇ 45 °
- the light scattering rate was calculated according to the equation (1) shown in Evaluation Example 1. Further, the reflection intensity at 45 ° was measured.
- the results are shown in Table 6.
- the cellulose particles obtained in Examples 1 to 3 were used.
- commercially available cellulose particles CELLULOBEADS D-10 (Daito Kasei Kogyo Co., Ltd.) and Cellflow C-25 (JNC Co., Ltd.) were used. The results are shown in Table 7.
- the particles of the present invention are natural materials that are soft and have excellent light scattering properties. Therefore, it can be applied to the industrial field as a light diffusing agent or the like.
- the particles of the present invention have an excellent optical characteristic that the degree of crystallinity is moderately suppressed, the surface has a ridge-like or ridge-like concavo-convex structure, and the incident light is uniformly scattered. Since it has a light scattering property, it can be expected to develop a defocus effect (also referred to as a soft focus effect). Therefore, it is preferably applied to the cosmetics field that directly touches the skin.
- the particles of the present invention are also excellent in oil absorption, they are suitable for addition to cosmetics containing an oil component and an oil base.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Geometry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Cosmetics (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Description
(2) 光散乱率が50~230%の範囲にある、セルロース又はセルロース誘導体を主成分として含む、粒子。
(3) 光散乱率が50~230%の範囲にある、上記(1)に記載の粒子。
(4) 結晶化度が80%以下である、上記(2)に記載の粒子。
(5) セルロースが、植物由来のセルロース、セルロースファイバー又はセルロースナノファイバーである、上記(1)乃至(4)に記載の粒子。
(6) セルロース又はセルロース誘導体の分散液を得る工程と、得られた分散液を噴霧乾燥する工程を含む、表面に皺状又は襞状の凹凸構造を有し、結晶化度が80%以下である、セルロース又はセルロース誘導体を主成分とする粒子の製造方法。
(7) セルロース又はセルロース誘導体の分散液を得る工程と、得られた分散液を噴霧乾燥する工程を含む、光散乱率が50~230%の範囲にあり、セルロース又はセルロース誘導体を主成分とする粒子の製造方法。
(8)セルロース又はセルロース誘導体を主成分とする粒子の光散乱率が50~230%の範囲にある、(6)に記載の製造方法。
(9) セルロース又はセルロース誘導体を主成分とする粒子の結晶化度が80%以下である、上記(7)に記載の製造方法。
(10) セルロースが、植物由来のセルロース、セルロースファイバー又はセルロースナノファイバーである、上記(6)乃至(9)に記載の製造方法。
(11) 分散液におけるセルロース又はセルロース誘導体の濃度が、0.5~5質量%である、上記(6)乃至(10)のいずれかに記載の製造方法。
(12) 分散液が、セルロース又はセルロース誘導体の物理的な粉砕により得られる、上記(6)乃至(11)のいずれかに記載の製造方法。
(13) 上記(1)乃至(5)のいずれかに記載の粒子、あるいは上記(6)乃至(12)のいずれかに記載の製造方法により得られる粒子を含む、化粧品。
本発明は、表面に皺状又は襞状の凹凸構造を有し、セルロース又はセルロース誘導体を主成分として含む、粒子に関する。「皺状又は襞状の凹凸構造を有する」とは、図3に示すように、粒子の拡大像を観察した際に、その表面が平滑ではなく、皺状又は襞状の外観を有する溝状の筋目を有することを意味する。これは、他の多孔性球状セルロース粒子に見られる半球状のクレーターのような窪みとは異なり、花弁状粒子に見られる不定形の凹凸構造を示す。
本発明の粒子は、セルロース又はセルロース誘導体を主成分として含む。本発明で使用されるセルロース又はセルロース誘導体は、羊毛、綿、絹、麻、パルプ等の天然繊維、レーヨン、ポリノジック、キュプラ(ベンベルグ(登録商標))、リヨセル(テンセル(登録商標))等の再生繊維に由来するもの、あるいはバクテリアが生産するセルロースが挙げられる。またセルロース繊維と合成繊維(例えば、ポリエチレン、ポリプロピレン等のポリオレフィン系繊維)のセルロース複合繊維に由来するものであってもよい。
別の態様において、本発明の粒子は、下記式(1)で表される光散乱率が、50~200%の範囲にあることを特徴とする。
{式(1)中、角度20°、70°及び5°での反射強度は、粒子に対して法線方向を0°として、粒子に-30°の角度から光を入射した時の受光器の感度を任意の値(感度調整値と呼ぶ)に設定した後、ある角度から光を入射した時の受光器の角度が20°、70°及び5°における反射光の強度を意味する。}
別の態様において、本発明の粒子は、結晶化度が80%以下であることを特徴とする。本発明の結晶化度は、粒子中のセルロースにおける結晶領域の割合を意味し、後述する評価例6に記載のとおり、粉末X線回折図から下記式(2)及び(3)(SEN-I GAKKAISHI, Vol.46, No.8(1990),324参照)を用いて算出することができる。
(式中、I22.6とI18.5は回折角2θが22.6°と18.5°における回折強度を示し、I22.6,blankとI18.5,blankは回折角2θが22.6°と18.5°におけるガラスキャピラリーのみの回折強度を示す。)
(式中、I20.0とI15.0は回折角2θが20.0°と15.0°における回折強度を示し、I20.0,blankとI15.0,blankは各々回折角2θが20.0°と15.0°におけるガラスキャピラリーのみの回折強度を示す。)
別の態様において、本発明の粒子は、JIS K 5101-13-1に準じて測定した吸油量が、60~150g/100gの範囲であることを特徴とする。具体的には、本発明の粒子を測定板の上に置き、精製あまに油をスポットから一回に数滴ずつ徐々に加え、その都度、ヘラで精製あまに油と粒子を混練する操作を繰り返し、精製あまに油及び粒子の塊ができるまで滴下を続け、次いで1滴ずつ滴下し、完全に混練するようにして繰り返し、ペーストが滑らかな硬さになったところを終点として、測定試料(g)に対する精製あまに油(g)から吸油量を算出する。本発明の粒子の吸油量は、60~150g/100gの範囲であり、好ましくは60~100g/100gの範囲であり、油性成分や油性基剤を含む化粧品への添加に適している。
本発明の粒子は、セルロース又はセルロース誘導体の分散液を得る工程と、得られた分散液を噴霧乾燥する工程を含む方法により製造できる。
本発明の粒子は、結晶化度が適度に抑制され、その表面に皺状又は襞状の凹凸構造を有することから柔らかく、また入射光が均一に光散乱するという優れた光学特性(光散乱性)を有することから、肌に直接触れ、かつデフォーカス効果等の光学特性が要求される化粧品への添加に適している。また本発明の粒子は、それ自体を、あるいはその用途に応じた適切な媒体中で任意の添加剤と共に分散された形態で、化粧品用添加剤又は化粧品用組成物として利用してもよい。そのような化粧品の例としては、洗顔フォーム、洗顔パウダー、ボディ洗浄料等のトイレタリー製品、シャンプー、コンディショナー等のヘアケア製品、歯磨剤等のオーラルケア製品、化粧下地、パウダーファンデーション、リキッドファンデーション、BBクリーム、コンシーラー、日焼け止め等のメーキャップ化粧品等が挙げられ、これらにおいて、マッサージ効果や洗浄効果を増強するためのスクラブ剤として、又はデフォーカス効果を発現させるための光散乱剤などとして使用できる。特に本発明の粒子は、吸油性に優れることから、油性成分や油性基剤を含む化粧品への添加に適している。
本発明の化粧品には、必要に応じて一般的に化粧品用添加剤及び医薬部外品用添加剤として使用可能な添加剤を配合することができる。化粧品又は医薬部外品等の皮膚外用剤に配合される生理活性物質及び機能性物質等の添加成分としては、例えば油性基剤、保湿剤、感触向上剤、界面活性剤、高分子、増粘・ゲル化剤、溶剤、噴射剤、酸化防止剤、還元剤、酸化剤、防腐剤、抗菌剤、殺菌剤、キレート剤、pH調整剤、酸、アルカリ、粉体、無機塩類、紫外線吸収剤、美白剤、ビタミン類及びその誘導体類、育毛用薬剤、血行促進剤、刺激剤、ホルモン類、抗しわ剤、抗老化剤、ひきしめ剤、冷感剤、温感剤、創傷治癒促進剤、刺激緩和剤、鎮痛剤、細胞賦活剤、植物・動物・微生物エキス類、鎮痒剤、角質剥離・溶解剤、制汗剤、清涼剤、収れん剤、酵素類、核酸類、香料、色素、着色剤、染料、顔料、消炎剤、抗炎症剤、抗喘息薬、抗慢性閉塞性肺疾患薬、抗アレルギー剤、免疫調整剤、抗感染症剤及び抗真菌剤等が挙げられる。
脂質、部分水素添加大豆リン脂質、水素添加卵黄リン脂質、部分水素添加卵黄リン脂質、水酸化レシチン等のリン脂質類;シリコーン系両性界面活性剤等;高分子界面活性剤としては、ポリビニルアルコール、アルギン酸ナトリウム、デンプン誘導体、トラガントガム、アクリル酸・メタアクリル酸アルキル共重合体;シリコーン系各種界面活性剤が好ましいものとして挙げられる。
酸化剤としては、過酸化水素水、過硫酸アンモニウム、臭素酸ナトリウム、過炭酸等が好ましいものとして挙げられる。
固形分が10質量%の竹由来セルロースナノファイバー(中越パルプ工業(株)製)407gに純水1343gを加えた後、メカニカルスターラーにて1時間撹拌し、セルロースナノファイバーを分散させた。この分散液を湿式微粒化装置スターバースト((株)スギノマシン製)により、220MPaの圧力で50回粉砕処理し、竹由来セルロースナノファイバー分散液を得た。得られた分散液をシャーレに10g量りとり、105℃にて1時間乾燥を行い、水分を除去した。得られた残渣の量を測定し、乾燥前後の重量差から水中のセルロース濃度(固形分濃度)を算出した。その結果、濃度は2.0質量%であった。
先述の竹由来セルロースナノファイバー分散液1575gを、アトマイザー回転速度30000rpm、入口温度180℃、サイクロン差圧0.5kPaで75分間噴霧乾燥し、標題粒子として22.6gの粉末を得た。この間、出口温度は130℃から117℃の間で推移した。
固形分が2質量%の広葉樹由来セルロースナノファイバー(大王製紙(株)製)400gに純水400gを加えた後、メカニカルスターラーにて1時間撹拌し、広葉樹由来セルロースナノファイバーを分散させた。この分散液800gを、アトマイザー回転速度30000rpm、入口温度182℃、サイクロン差圧0.5kPaで26分間噴霧乾燥し、標題粒子
として1.01gの粉末を得た。この間、出口温度は102℃から77℃の間で推移した。
固形分が2質量%の針葉樹由来セルロースナノファイバー(大王製紙(株)製)400gに純水400gを加えた後、メカニカルスターラーにて1時間撹拌を行い、針葉樹由来セルロースナノファイバーを分散させた。この分散液800gを、アトマイザー回転速度30000rpm、入口温度178℃、サイクロン差圧0.5kPaで26分間噴霧乾燥し、標題粒子として2.70gの粉末を得た。この間、出口温度は17℃で一定であった。
結晶性セルロース((株)伏見製薬所 コンプレッセルM101)75gを純水750gに分散させた。この分散液を湿式微粒化装置スターバースト((株)スギノマシン製)により、220MPaの圧力で30回粉砕処理し、結晶性セルロース分散液を得た。得られた分散液をシャーレに10g量りとり、105℃にて1時間乾燥を行い、水分を除去した。得られた残渣の量を測定し、乾燥前後の重量差から水中のセルロース濃度(固形分濃度)を算出した。その結果、濃度は4.0質量%であった。
先述の結晶性セルロース分散液250gに純水250gを加え結晶性セルロース分散液2.0質量%を調製し、アトマイザー回転速度20000rpm、入口温度160℃、サイクロン差圧0.5kPaで23分間噴霧乾燥し、標題粒子として4.6gの粉末を得た。この間、出口温度は109℃から95℃の間で推移した。
実施例4で得られた4.0質量%結晶性セルロース分散液500gを、アトマイザー回転速度20000rpm、入口温度160℃、サイクロン差圧0.5kPaで25分間噴霧乾燥し、標題粒子として12.1gの粉末を得た。この間、出口温度は109℃から93℃の間で推移した。
マイクロスライドガラスS1111(松浪硝子工業(株)製)上にナイスタック(登録商標)NW-10S(ニチバン(株)製)を用いて、黒色の画用紙PI-N86D((株)マルアイ製)を貼り付けた。次いで、上述の黒色画用紙の上にナイスタック(登録商標)NW-10Sを貼付し、その上にサンプル粉末を押し当てた後、余分な粉末を圧力0.2MPaに調整したエアーガンにて除いた。反射光分布の測定は、変角光度計GP-5((株)村上色彩技術研究所製)にて実施した。測定入射光は-30、-45および-60°の3点で実施した。各入射光角度における光散乱率は、下記式(1)に従って算出した(国際公開第2010/092890号参照)。
実施例1乃至3で得られた竹、広葉樹、及び針葉樹由来のセルロース粒子と実施例4及び5で得られた結晶性セルロース粒子由来のセルロース粒子をサンプルに用いた。各サンプルをカーボンテープに貼付し、走査型電子顕微鏡Miniscope(登録商標)TM3000((株)日立ハイテクノロジーズ製)を用いて形態観察を実施した。各セルロース粒子の形態観察結果をそれぞれ図3(a)乃至(e)に示した。
主剤として50mLのEpok 812、硬化剤として44.5mLのMethyl Nadic Anhydride、及び重合促進剤として1.3mLのTri-Dimethyl Aminomethyl Phenolから成る熱硬化樹脂混合液中に、実施例1の竹由来セルロース粒子を包埋し、60℃で12時間加熱して、硬化させた。得られた硬化物からウルトラミクロトーム(Leica Microsystems社製)にて150nm厚の薄片を作成し、薄片化した試料をシートメッシュにサンプリングし透過型電子顕微鏡で観察した。結果を図4に示した。
ENT-2100((株)エリオニクス製)にて実施例1で得られた竹由来セルロース粒子と、比較例1の市販のセルロース粒子CELLULOBEADS D-10(大東化成工業(株)製)の硬度を測定した。φ50μmフラット圧子を使用し、設定荷重を20mN、負荷時間を10秒に設定した。シリコン基板上に各試料を散布し、5粒子ずつ測定した後、得られた測定値の平均値を算出した。その結果、竹由来セルロース粒子の硬度は23.75MPaであり、CELLULOBEADS D-10の硬度は42.91MPaであった。
各サンプル0.3gを秤量し、10mm角シリコン素材センサーを備えた摩擦感テスターKES-SE(カトーテック(株)製)にて摩擦係数と摩擦係数の変動を評価した。各サンプルの測定は5回実施した。サンプルは、実施例1で得られた竹由来セルロース粒子と、対照としてCELLULOBEADS D-10(大東化成工業(株)製)及び東レナイロン微粒子SP-10(東レ(株)製)を用いた。なお、センサーは10mm角シリコンワイヤーを用い、測定距離を20mm、静荷重を25gf、測定速度を1.0mm/sec、接触面幅を10mmに設定した。結果を図5及び図6に示した。
図5中、MMDは平均摩擦係数の変動を指し、人の指で物体の表面を触るときに感じる、なめらかさやざらつき感を表す指標である。MMDの数値が小さいほど、なめらかである。
図6中、MIUは平均摩擦係数を指し、人の指で物体の表面を触るときに感じる、すべりやすさやすべりにくさを表す指標である。MIUの数値が小さいほどすべりやすい。
リンデマンガラスキャピラリー(φ0.7mm)に各サンプル粉末を封入し、X’Pert PRO MPD(PANalytical製)を用いて粉末X線回折測定を実施した。X線源としてCu/Kα-radiationを用い,管電圧を45kV,管電流を40mA,測定範囲を回折角2θ=5~50°、ステップ幅を0.05°、平均時間/STEPを500秒/STEPで測定した。サンプルとして、実施例1及び3で得られたセルロース粒子と、比較例1の市販のセルロース粒子CELLULOBEADS D-10を用いた。各々のX線回折図を図7(a)乃至(c)に示した。
図7(a)及び(b)から、実施例1及び3で得られたセルロース粒子の結晶形は同一であることがわかった(以下、I型結晶形と呼称する)。一方で、図7(a)及び(b)と図7(c)の比較から、CELLULOBEADS D-10の結晶形は、実施例1又は3で得られたセルロース粒子とは異なることがわかった(以下、II型結晶形と呼称する)。
次に、得られた粉末X線回折図から各々の粒子の結晶化度を算出した。結晶化度の算出には下記式(2)及び(3)を用いた(SEN-I GAKKAISHI, Vol.46, No.8(1990),324参照)。
(式中、I22.6とI18.5は回折角2θが22.6°と18.5°における回折強度を示し、I22.6,blankとI18.5,blankは回折角2θが22.6°と18.5°におけるガラスキャピラリーのみの回折強度を示す。)
(式中、I20.0とI15.0は回折角2θが20.0°と15.0°における回折強度を示し、I20.0,blankとI15.0,blankは各々回折角2θが20.0°と15.0°におけるガラスキャピラリーのみの回折強度を示す。)
散乱式粒子径分布測定装置LA-960((株)堀場製作所製)を用いて、サンプル溶液を循環速度3、撹拌速度2にて循環させた状態で、半導体レーザ(650nm)及び発光ダイオード(405nm)の透過率が90.0%以下になるように各種サンプル濃度を調製した。濃度調製後、超音波強度3で超音波を1分間照射した後に粒径測定を実施した。結果を図8(a)乃至(e)に示した。
表5に従い、300mLトールビーカー2つにA相、B相をそれぞれ量り取り、各々75℃程度で加熱溶解した。前述の加熱したB相にA相を添加し、QUICK HOMO MIXER(みづほ工業(株)製、5000rpm、3分間)処理を実施した。その後、液温が35℃程度になるまでLABORATORY HIGH POWER MIXER(アズワン(株)製)で攪拌冷却した。容量1.5mLのマイクロチューブSTF-15((株)三晶製)に、作製したwater in oil(以下、w/oと略す)ファンデーション液450mg、評価粒子粉末50mgを各々量り取り、薬さじで均一に混錬することで各評価粒子を5%含有するw/oファンデーションサンプルを調製した。評価粒子として、実施例1乃至3で得られたセルロース粒子を用いた。また、比較例として、市販のセルロース粒子CELLULOBEADS D-10(大東化成工業(株)製)を用いた。
SILBLEND-91:シクロペンタシロキサン、ジメチコン、(ジメチコン/ビニルジメチコン)クロスポリマー
KF-96L-2CS:ジメチコン
KF6028:PEG-9ポリジメチルシロキシエチルジメチコン
DISM:リンゴ酸ジイソステアリル
FAS70CSI-E:酸化チタン分散物(酸化チタン、シクロペンタシロキサン、PEG/PPG-18/18ジメチコン、トリエトキシカプリリルシラン、アルミナ、酢酸トコフェロール、シリカ)
フレッシュカラーベース:酸化チタン、シクロペンタシロキサン、PEG/PPG-18/18ジメチコン、酸化鉄、メチコン、酢酸トコフェロール
1,3-BG:1,3-ブチレングリコール
EDTA-2Na:エチレンジアミン四酢酸二ナトリウム塩
JIS規格(K 5101-13-1:2004 (ISO 787-5:1980))を参考に吸油量評価を行った。秤量皿へ秤量した評価粒子粉末に対し、あまに油(サミット製油(株)製)をスポイトで徐々に滴下し、都度ヘラで混錬する操作を繰り返し、あまに油及び評価粒子の塊ができるまで滴下を続けた。粉末が滑らかなペースト状となったところを終点とした。このペーストは、割れたり、ぼろぼろになったりせず広げることができ、かつ、測定板に軽く付着する程度のものとする。終点における評価粒子粉末重量(g)に対する亜麻仁油滴下量(g)から、吸油量(g/100g)を算出した。評価粒子として、実施例1乃至3で得られたセルロース粒子を用いた。また、比較例として、市販のセルロース粒子CELLULOBEADS D-10(大東化成工業(株)製)及びセルフロー C-25(JNC(株)製)を用いた。結果を表7に示す。
Claims (13)
- 表面に皺状又は襞状の凹凸構造を有し、結晶化度が80%以下である、セルロース又はセルロース誘導体を主成分として含む、粒子。
- 光散乱率が50~230%の範囲にある、セルロース又はセルロース誘導体を主成分として含む、粒子。
- 光散乱率が、50~230%の範囲にある、請求項1に記載の粒子。
- 結晶化度が80%以下である、請求項2に記載の粒子。
- セルロースが、植物由来のセルロース、セルロースファイバー又はセルロースナノファイバーである、請求項1乃至4のいずれかに記載の粒子。
- セルロース又はセルロース誘導体の分散液を得る工程と、得られた分散液を噴霧乾燥する工程を含む、表面に皺状又は襞状の凹凸構造を有し、結晶化度が80%以下である、セルロース又はセルロース誘導体を主成分とする粒子の製造方法。
- セルロース又はセルロース誘導体の分散液を得る工程と、得られた分散液を噴霧乾燥する工程を含む、光散乱率が50~230%の範囲にあり、セルロース又はセルロース誘導体を主成分とする粒子の製造方法。
- セルロース又はセルロース誘導体を主成分とする粒子の光散乱率が50~230%の範囲にある、請求項6に記載の製造方法。
- セルロース又はセルロース誘導体を主成分とする粒子の結晶化度が80%以下である、請求項7に記載の製造方法。
- セルロースが、植物由来のセルロース、セルロースファイバー又はセルロースナノファイバーである、請求項6乃至9のいずれかに記載の製造方法。
- 分散液におけるセルロース又はセルロース誘導体の濃度が、0.5~5質量%である、請求項6乃至10のいずれかに記載の製造方法。
- 分散液が、セルロース又はセルロース誘導体の物理的な粉砕により得られる、請求項6乃至11のいずれかに記載の製造方法。
- 請求項1乃至5のいずれかに記載の粒子、あるいは請求項6乃至12のいずれかに記載の製造方法により得られる粒子を含む、化粧品。
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201980010775.8A CN111655736A (zh) | 2018-02-01 | 2019-02-01 | 功能性多糖粒子 |
KR1020207024768A KR20200116478A (ko) | 2018-02-01 | 2019-02-01 | 기능성 다당 입자 |
JP2019569612A JPWO2019151486A1 (ja) | 2018-02-01 | 2019-02-01 | 機能性多糖粒子 |
EP19747667.4A EP3747911A4 (en) | 2018-02-01 | 2019-02-01 | FUNCTIONAL PARTICLE OF POLYSACCHARIDE |
US16/966,816 US20200360261A1 (en) | 2018-02-01 | 2019-02-01 | Functional polysaccharide particle |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018016310 | 2018-02-01 | ||
JP2018-016310 | 2018-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2019151486A1 true WO2019151486A1 (ja) | 2019-08-08 |
Family
ID=67479321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2019/003646 WO2019151486A1 (ja) | 2018-02-01 | 2019-02-01 | 機能性多糖粒子 |
Country Status (7)
Country | Link |
---|---|
US (1) | US20200360261A1 (ja) |
EP (1) | EP3747911A4 (ja) |
JP (1) | JPWO2019151486A1 (ja) |
KR (1) | KR20200116478A (ja) |
CN (1) | CN111655736A (ja) |
TW (1) | TW201940521A (ja) |
WO (1) | WO2019151486A1 (ja) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020246510A1 (ja) * | 2019-06-06 | 2020-12-10 | 凸版印刷株式会社 | 複合粒子およびその製造方法、パーソナルケア製品、パーソナルケア用粒子およびその製造方法、パーソナルケア用品、パーソナルケア用組成物 |
WO2021020560A1 (ja) * | 2019-07-31 | 2021-02-04 | 日産化学株式会社 | セルロースを含有する顔料 |
JP2021042271A (ja) * | 2019-09-06 | 2021-03-18 | 凸版印刷株式会社 | 複合粒子、複合粒子の製造方法、複合粒子を含むパーソナルケア製品 |
WO2021145450A1 (ja) * | 2020-01-17 | 2021-07-22 | 日産化学株式会社 | 紫外線防御用粒子状組成物 |
WO2021182498A1 (ja) * | 2020-03-11 | 2021-09-16 | 日産化学株式会社 | 多糖複合粒子 |
WO2024085087A1 (ja) * | 2022-10-18 | 2024-04-25 | 旭化成株式会社 | セルロース粒子 |
US12075775B2 (en) | 2018-04-27 | 2024-09-03 | Toppan Printing Co., Ltd. | Sustained-release composite particles, method for producing sustained-release composite particles, dry powder, and wallpaper |
EP4438660A1 (en) | 2023-03-29 | 2024-10-02 | FUJIFILM Business Innovation Corp. | Cellulose particles |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112175243B (zh) * | 2020-09-21 | 2023-05-05 | 桂林理工大学 | 一种高性能醋酸纤维素复合材料及其制备方法 |
CN112618481B (zh) * | 2021-02-22 | 2021-11-09 | 山东第一医科大学附属省立医院(山东省立医院) | 一种改性水凝胶、改性水凝胶微球及其制备方法和应用 |
CN114250178B (zh) * | 2021-12-21 | 2024-01-23 | 泰伦特生物工程股份有限公司 | 一种用于去除金属表面有机物的微生物制剂及其制备方法 |
CN115141292B (zh) * | 2022-07-18 | 2023-04-14 | 福州大学 | 全生物质自组装单组份膨胀型阻燃剂及其制备方法和应用 |
CN116199800B (zh) * | 2023-02-08 | 2024-02-27 | 中国林业科学研究院林产化学工业研究所 | 一种具有抗弧菌活性的壳聚糖-柠檬醛-钙盐复合物的制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09132601A (ja) | 1995-09-06 | 1997-05-20 | Bio Polymer Res:Kk | 多孔性セルロース粒子の製造方法 |
WO2007003697A1 (en) | 2005-07-01 | 2007-01-11 | M-Real Oyj | Method for coating cellulose particles, coated cellulose particles, and use thereof in paper and board production |
WO2010092890A1 (ja) | 2009-02-10 | 2010-08-19 | 綜研化学株式会社 | 被覆粒子およびその製造方法 |
JP2014118521A (ja) * | 2012-12-18 | 2014-06-30 | Kao Corp | セルロースナノファイバー分散液の製造方法 |
JP2016040264A (ja) | 2012-09-26 | 2016-03-24 | 積水化成品工業株式会社 | 多孔質樹脂粒子、多孔質樹脂粒子の製造方法、およびその用途 |
WO2017056908A1 (ja) | 2015-09-30 | 2017-04-06 | 積水化成品工業株式会社 | 多孔質樹脂微粒子及びその製造方法 |
JP2017078145A (ja) * | 2015-10-22 | 2017-04-27 | 大王製紙株式会社 | セルロースナノファイバー乾燥体の製造方法 |
WO2017073626A1 (ja) | 2015-10-30 | 2017-05-04 | 東レ株式会社 | エーテル系セルロース誘導体微粒子 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6247207B2 (ja) * | 2012-05-31 | 2017-12-13 | 旭化成株式会社 | セルロース粉末 |
-
2019
- 2019-02-01 KR KR1020207024768A patent/KR20200116478A/ko not_active Application Discontinuation
- 2019-02-01 JP JP2019569612A patent/JPWO2019151486A1/ja not_active Withdrawn
- 2019-02-01 WO PCT/JP2019/003646 patent/WO2019151486A1/ja active Application Filing
- 2019-02-01 EP EP19747667.4A patent/EP3747911A4/en not_active Withdrawn
- 2019-02-01 US US16/966,816 patent/US20200360261A1/en not_active Abandoned
- 2019-02-01 CN CN201980010775.8A patent/CN111655736A/zh active Pending
- 2019-02-01 TW TW108104227A patent/TW201940521A/zh unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09132601A (ja) | 1995-09-06 | 1997-05-20 | Bio Polymer Res:Kk | 多孔性セルロース粒子の製造方法 |
WO2007003697A1 (en) | 2005-07-01 | 2007-01-11 | M-Real Oyj | Method for coating cellulose particles, coated cellulose particles, and use thereof in paper and board production |
WO2010092890A1 (ja) | 2009-02-10 | 2010-08-19 | 綜研化学株式会社 | 被覆粒子およびその製造方法 |
JP2016040264A (ja) | 2012-09-26 | 2016-03-24 | 積水化成品工業株式会社 | 多孔質樹脂粒子、多孔質樹脂粒子の製造方法、およびその用途 |
JP2014118521A (ja) * | 2012-12-18 | 2014-06-30 | Kao Corp | セルロースナノファイバー分散液の製造方法 |
WO2017056908A1 (ja) | 2015-09-30 | 2017-04-06 | 積水化成品工業株式会社 | 多孔質樹脂微粒子及びその製造方法 |
JP2017078145A (ja) * | 2015-10-22 | 2017-04-27 | 大王製紙株式会社 | セルロースナノファイバー乾燥体の製造方法 |
WO2017073626A1 (ja) | 2015-10-30 | 2017-05-04 | 東レ株式会社 | エーテル系セルロース誘導体微粒子 |
Non-Patent Citations (8)
Title |
---|
"Concise Encyclopedia of Polymer Science and Engineering", 20 September 1994, MARUZEN, pages: 556-557, 1358 |
ISOGAI, AKIRA: "Cellulose : It's Higher-order Structures and Functionalities", JOURNAL OF THE TEXTILE MACHINERY SOCIETY OF JAPAN, vol. 50, no. 4, pages 181 - 185 * |
ISOGAI, AKIRA: "Composite Materials of TEMPO- Oxidized Cellulose Single Nanofiber", NIPPON GOMU KYOKAISHI, vol. 85, no. 12, 2012, pages 388 - 393, XP055394844, DOI: 10.2324/gomu.85.388 * |
KOJIRO UETANI, HIROYUKI YANO: "P59 Structure control of nanocellulose via droplet evaporation", LECTURE ABSTRACTS OF THE 19TH ANNUAL MEETING OF THE CELLULOSE SOCIETY OF JAPAN, vol. 19, 1 July 2012 (2012-07-01), pages 108, XP009522627 * |
KOJIRO UETANI; HIROYUKI YANO: "Self-organizing capacity of nanocelluloses via droplet evaporation", SOFT MATTER (PRINT), ROYAL SOCIETY OF CHEMISTRY, GB, vol. 9, no. 12, 28 March 2013 (2013-03-28), GB , pages 3396 - 3401, XP009522628, ISSN: 1744-683X, DOI: 10.1039/C3SM27822K |
KOJIRO UETANI; HIROYUKI YANO: "Self-organizing capacity of nanocelluloses via droplet evaporation", SOFT MATTER, vol. 9, no. 12, 2013, pages 3396 - 3401, XP009522628, DOI: 10.1039/C3SM27822K * |
NAKATSUBO, FUMIAKI: "Nanofibers produced by organisms'', - Cellulose nanofibers, Development of expanding application - summary", CHEMICAL ALTERATION STRATEGY OF CELLULOSE NANOFIBERS, February 2013 (2013-02-01), pages 1 - 6, XP055628625, Retrieved from the Internet <URL:http://www.rish.kyoto-u.ac.jp/labm/wp-content/uploads/2013/04/cellulosesymposium2013.pdf> * |
SEN-I GAKKAISHI, vol. 46, no. 8, 1990, pages 324 |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12075775B2 (en) | 2018-04-27 | 2024-09-03 | Toppan Printing Co., Ltd. | Sustained-release composite particles, method for producing sustained-release composite particles, dry powder, and wallpaper |
WO2020246510A1 (ja) * | 2019-06-06 | 2020-12-10 | 凸版印刷株式会社 | 複合粒子およびその製造方法、パーソナルケア製品、パーソナルケア用粒子およびその製造方法、パーソナルケア用品、パーソナルケア用組成物 |
WO2021020560A1 (ja) * | 2019-07-31 | 2021-02-04 | 日産化学株式会社 | セルロースを含有する顔料 |
JP2021042271A (ja) * | 2019-09-06 | 2021-03-18 | 凸版印刷株式会社 | 複合粒子、複合粒子の製造方法、複合粒子を含むパーソナルケア製品 |
JP7463676B2 (ja) | 2019-09-06 | 2024-04-09 | Toppanホールディングス株式会社 | 複合粒子、複合粒子の製造方法、複合粒子を含むパーソナルケア製品 |
WO2021145450A1 (ja) * | 2020-01-17 | 2021-07-22 | 日産化学株式会社 | 紫外線防御用粒子状組成物 |
WO2021182498A1 (ja) * | 2020-03-11 | 2021-09-16 | 日産化学株式会社 | 多糖複合粒子 |
WO2024085087A1 (ja) * | 2022-10-18 | 2024-04-25 | 旭化成株式会社 | セルロース粒子 |
EP4438660A1 (en) | 2023-03-29 | 2024-10-02 | FUJIFILM Business Innovation Corp. | Cellulose particles |
Also Published As
Publication number | Publication date |
---|---|
TW201940521A (zh) | 2019-10-16 |
EP3747911A1 (en) | 2020-12-09 |
KR20200116478A (ko) | 2020-10-12 |
CN111655736A (zh) | 2020-09-11 |
US20200360261A1 (en) | 2020-11-19 |
JPWO2019151486A1 (ja) | 2021-01-14 |
EP3747911A4 (en) | 2021-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2019151486A1 (ja) | 機能性多糖粒子 | |
JP5904949B2 (ja) | 脂質ペプチド型ゲル化剤と高分子化合物とを含有するゲルシート | |
JP6274440B2 (ja) | 分散液及びヒドロゲル形成方法 | |
JP5971487B2 (ja) | 化粧料の製造方法、化粧料用ゲルの調製方法及び化粧料原料に配合される高分子増粘剤の使用量を軽減する方法 | |
JP6132108B2 (ja) | ヒドロゲル形成材料、プレミックス及びヒドロゲル形成方法 | |
WO2011052613A1 (ja) | 化粧料及び皮膚外用剤、並びに医療用機器 | |
JP5214102B2 (ja) | クレンジング用の化粧料 | |
WO2015005219A1 (ja) | 分散液及びヒドロゲル形成方法 | |
JP2010070492A (ja) | 化粧料 | |
WO2016121867A1 (ja) | 脂質ペプチド型化合物を含有する経皮吸収基材 | |
WO2016121822A1 (ja) | 脂質ペプチド型化合物を含有する保湿基材 | |
WO2016208473A1 (ja) | 脂質ペプチド型化合物を含有するスティック状基材 | |
JP2015051961A (ja) | 経皮吸収基材 | |
WO2020004649A1 (ja) | 被膜形成組成物 | |
JP2008143838A (ja) | 表面処理粉体を含有する化粧料 | |
WO2021020560A1 (ja) | セルロースを含有する顔料 | |
JP6613486B2 (ja) | 脂質ペプチド型化合物を含有する増粘性組成物 | |
JPWO2016208460A1 (ja) | 脂質ペプチド型化合物を含有するスティック状基材の硬度調整方法 | |
WO2018117156A1 (ja) | スティック状皮膚外用固形基材 | |
WO2018190383A1 (ja) | 顔料又は粉体用分散剤を含有する分散液 | |
WO2018207947A1 (ja) | 多糖含有スティック状基材 | |
WO2022092284A1 (ja) | 脂質ペプチドとショ糖エステルを含む組成物 | |
JP2023084306A (ja) | セルロースを含有する複合顔料の製造法 | |
JP2023048158A (ja) | 脂質ペプチドとノニオン性界面活性剤を含む機能性液状組成物 | |
WO2018207948A1 (ja) | 高含水スティック状基材 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 19747667 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2019569612 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20207024768 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2019747667 Country of ref document: EP Effective date: 20200901 |